Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An open label six month study to evaluate the safety and efficacy of nitrogen mustard (NM) [chlormethine] 0.04% ointment formulation in patients with stage I or IIA mycosis fungoides (MF) who have completed an initial 12 month treatment with nitrogen mustard 0.02% but without a complete response.

Trial Profile

An open label six month study to evaluate the safety and efficacy of nitrogen mustard (NM) [chlormethine] 0.04% ointment formulation in patients with stage I or IIA mycosis fungoides (MF) who have completed an initial 12 month treatment with nitrogen mustard 0.02% but without a complete response.

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Jun 2014

At a glance

  • Drugs Chlormethine (Primary)
  • Indications Mycosis fungoides
  • Focus Therapeutic Use
  • Sponsors Actelion Pharmaceuticals
  • Most Recent Events

    • 06 Dec 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
    • 06 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Nov 2010 Planned end date changed from 1 Mar 2011 to 1 Feb 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top